Citi analyst David Hoang lowered ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change

Acadia Pharmaceuticals (ACAD) Stock Selloff Is Over Done Says UBS, 'the level of sell-off is surprising to us'March 12, 2024 4:07 PM Acadia Pharma (ACAD) to stop pimavanserin trials after failureMarch 12, 2024 12:52 PM Mizuho Downgrades Acadia Pharmaceuticals (ACAD) to NeutralMarch 12, 2024 4:51 AM